Scientists are excitedly investigating retatrutide, a promising treatment created by Eli Lilly, as a significant step in weight management. Different than many earlier approaches, retatrutide is a dual -action receptor targeting both GLP-1 and GIP, chemicals that impact satiety and glucose regulati